{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:30:45Z","timestamp":1794565845910,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007120","name":"Society of Thoracic Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA258681"],"award-info":[{"award-number":["R01 CA258681"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtho.2025.03.042","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T12:53:08Z","timestamp":1742734388000},"page":"1075-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anatomic Lung Resection Is Associated With Improved Survival Compared With Wedge Resection for Stage IA (\u22642 cm) NSCLC"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-1245","authenticated-orcid":false,"given":"Christopher W.","family":"Seder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Towe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Blasberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Bonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix G.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Kozower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2025.03.042_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2025.03.042_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.athoracsur.2025.01.010","article-title":"The Society of Thoracic Surgeons general thoracic surgery database: 2024 update on outcomes and research","volume":"119","author":"Towe","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtcvs.2023.09.014","article-title":"Commentary: segmentectomy versus lobectomy: are the findings of the JCOG 0802 and CALGB 140503 trials generalizable to the US population?","volume":"167","author":"Tohmasi","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib9","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.athoracsur.2013.04.124","article-title":"External validation of the Society of Thoracic Surgeons General Thoracic Surgery Database","volume":"96","author":"Magee","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(22)02471-0","article-title":"Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort","volume":"401","author":"Dixon","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2025.03.042_bib11","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.athoracsur.2024.07.047","article-title":"The Society of Thoracic Surgeons 2024 Risk models for lung cancer resection: continued refinement and improved outcomes","volume":"119","author":"Tong","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib13","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jtcvs.2023.07.008","article-title":"Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: a post hoc analysis of CALGB 140503 (Alliance)","volume":"167","author":"Altorki","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-10-37","article-title":"Making trials matter: pragmatic and explanatory trials and the problem of applicability","volume":"10","author":"Treweek","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.jtho.2025.03.042_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2014.09.004","article-title":"Non-small cell lung cancer: when to offer sublobar resection","volume":"86","author":"Sihoe","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2025.03.042_bib18","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2024.12.017","article-title":"Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High-Quality Wedge Resection for Early-Stage Lung Cancer","volume":"119","author":"Krantz","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.athoracsur.2025.01.004","article-title":"Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation","volume":"119","author":"Woodard","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.athoracsur.2018.07.059","article-title":"Penetration, completeness, and representativeness of the Society of Thoracic Surgeons general thoracic surgery database for lobectomy","volume":"107","author":"Tong","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive Summary of an ASTRO Evidence-Based Guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jtho.2025.03.042_bib23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","article-title":"Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtho.2025.03.042_bib24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2025.03.042_bib25","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.cllc.2020.04.017","article-title":"Oncologic outcomes of surgery versus SBRT for non\u2013small-cell lung carcinoma: a systematic review and meta-analysis","volume":"22","author":"Ijsseldijk","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2025.03.042_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.lungcan.2016.11.005","article-title":"Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients","volume":"103","author":"Samson","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2025.03.042_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.06.086","article-title":"Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: post hoc analysis dressed up as level-1 evidence?","volume":"150","author":"Meyers","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2025.03.042_bib28","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(24)01756-2","article-title":"Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Spicer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2025.03.042_bib30","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib31","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2025.03.042_bib32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2025.03.042_bib33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O\u2019Brien","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086425006410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086425006410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:16:26Z","timestamp":1785550586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086425006410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1556086425006410"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2025.03.042","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anatomic Lung Resection Is Associated With Improved Survival Compared With Wedge Resection for Stage IA (\u22642 cm) NSCLC","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2025.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}